Ab initio computational study of positron emission tomography ligands interacting with lipid molecule for the prediction of nonspecific binding

Nonspecific binding is a poorly understood biological phenomenon of relevance in the study of small molecules interactions in vivo and in drug development. Nonspecific binding is thought to be correlated in part to a molecule's lipophilicity, typically estimated by measuring (or calculating) octanol–water partition coefficient. This is, however, a gross simplification of a complex phenomenon. In this article, we present a computational method whose aim is to help identify positron emission tomography (PET) ligands with low nonspecific binding characteristics by investigating the molecular basis of ligand–membrane interaction. We considered a set consisting of 10 well‐studied central nervous system PET radiotracers acting on a variety of molecular targets. Quantum mechanical calculations were used to estimate the strength of the interaction between each drug molecule and one phospholipid molecule commonly present in mammalian membranes. The results indicate a correlation between the computed drug–lipid interaction energy and the in vivo nonspecific distribution volume relative to the free tracer plasma concentration, calculated using standard compartmental modeling for the analysis of PET data. Significantly, the drugs whose interaction with the lipid molecule more favorably possessed, in general, a higher nonspecific binding value, whereas for the drugs taken in consideration in this study, the water‐octanol partition coefficient, log P, did not show good predictive power of the nonspecific binding. This study also illustrates how ab initio chemical methods may offer meaningful and unbiased insights for the understanding of the underlying chemical mechanisms in biological systems. © 2008 Wiley Periodicals, Inc. J Comput Chem, 2008

[1]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[2]  Mark Slifstein,et al.  Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. , 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

[3]  P. Hohenberg,et al.  Inhomogeneous Electron Gas , 1964 .

[4]  J. Jankovic,et al.  Decreased [18F]Spiperone Binding in Putamen in Idiopathic Focal Dystonia , 1997, The Journal of Neuroscience.

[5]  C. Halldin,et al.  PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  Maurizio Recanatini,et al.  Target-related applications of first principles quantum chemical methods in drug design. , 2006, Chemical reviews.

[7]  Z Rattner,et al.  Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  K. Herholz,et al.  Brain receptor imaging. , 2010, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Koeppe,et al.  Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.

[10]  Mark Slifstein,et al.  Quantitative analysis of (-)-N-(11)C-propyl-norapomorphine in vivo binding in nonhuman primates. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  C D Marsden,et al.  Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study. , 1995, Brain : a journal of neurology.

[12]  Oscar Ces,et al.  Degradative transport of cationic amphiphilic drugs across phospholipid bilayers , 2006, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[13]  Maykel Cruz-Monteagudo,et al.  Computational chemistry development of a unified free energy Markov model for the distribution of 1300 chemicals to 38 different environmental or biological systems , 2007, J. Comput. Chem..

[14]  W. Kohn,et al.  Self-Consistent Equations Including Exchange and Correlation Effects , 1965 .

[15]  M. Wehling,et al.  The binding of drugs to different polar lipids in vitro. , 1979, Biochemical pharmacology.

[16]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[17]  Steen Jakobsen,et al.  Behaviour of [11C]R(−)‐ and [11C]S(+)‐rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4 , 2005, Synapse.

[18]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Osama Mawlawi,et al.  Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography: I. Accuracy and Precision of D2 Receptor Parameter Measurements in Ventral Striatum , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Alan A. Wilson,et al.  Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.

[21]  C. Halldin,et al.  Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Frank Alber,et al.  Quantum medicinal chemistry , 2003 .

[23]  B. Christian,et al.  Quantitation of striatal and extrastriatal D‐2 dopamine receptors using PET imaging of [18F]fallypride in nonhuman primates , 2000, Synapse.

[24]  E. Rabiner,et al.  PET studies in drug development: Methodological considerations. , 2005, Drug discovery today. Technologies.

[25]  V J Cunningham,et al.  11C-Diprenorphine Binding in Huntington's Disease: A Comparison of Region of Interest Analysis with Statistical Parametric Mapping , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  S. Schreier,et al.  Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. , 2000, Biochimica et biophysica acta.

[27]  Miquel Duran,et al.  How does basis set superposition error change the potential surfaces for hydrogen-bonded dimers? , 1996 .

[28]  Jacob Madsen,et al.  Neuroimaging of the serotonin reuptake site requires high‐affinity ligands , 2007, Synapse.

[29]  P. Somasundaran,et al.  Solution properties of amitriptyline and its partitioning into lipid bilayers. , 2004, Colloids and surfaces. B, Biointerfaces.

[30]  C. Halldin,et al.  Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  Mark Slifstein,et al.  Positron emission tomography: imaging and quantification of neurotransporter availability. , 2002, Methods.

[32]  A. Becke,et al.  Density-functional exchange-energy approximation with correct asymptotic behavior. , 1988, Physical review. A, General physics.

[33]  S. F. Boys,et al.  The calculation of small molecular interactions by the differences of separate total energies. Some procedures with reduced errors , 1970 .

[34]  Kenneth M Merz,et al.  Quantum mechanics in structure-based drug design. , 2006, Current opinion in drug discovery & development.

[35]  Paul L. A. Popelier,et al.  Quantum Molecular Similarity. 3. QTMS Descriptors , 2001, J. Chem. Inf. Comput. Sci..

[36]  John Ashburner,et al.  Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols , 1994, Journal of Neuroscience Methods.